Home > Boards > US Listed > Medical - Drugs > Merck & Co. Inc. (MRK)

MRK/AZN—Lynparza shows statsig-superior OS to hormonal agents (Xtandi,

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 748
Posts 115,220
Boards Moderated 14
Alias Born 09/05/02
160x600 placeholder
Merck announces positive mid-stage trial data for COVID-19 antiviral drug Seeking Alpha - 3/6/2021 9:07:57 PM
U.S. Scientists Skeptical of One-Shot Regimen for Pfizer, Moderna Covid Vaccines--3rd Update Dow Jones News - 3/6/2021 5:18:00 PM
U.S. Scientists Skeptical of One-Shot Regimen for Pfizer, Moderna Covid Vaccines--2nd Update Dow Jones News - 3/6/2021 5:00:00 PM
U.S. Scientists Skeptical of One-Shot Regimen for Pfizer, Moderna Covid Vaccines--Update Dow Jones News - 3/6/2021 4:47:00 PM
Covid-19 Pill Shows Promise in Preliminary Testing Dow Jones News - 3/6/2021 12:30:00 AM
Ridgeback Biotherapeutics & Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic... Business Wire - 3/6/2021 12:01:00 AM
Merck Begins Tender Offer to Acquire Pandion Therapeutics Business Wire - 3/4/2021 6:45:00 AM
Biden Expects U.S. to Have Enough Vaccines for All Adults by End of May -- 6th Update Dow Jones News - 3/3/2021 7:47:00 AM
Merck to Present New Data from Various HIV Research and Development Programs at CROI 2021 Business Wire - 3/3/2021 6:45:00 AM
Merck to Present at the Barclays Global Healthcare Conference Business Wire - 3/3/2021 6:45:00 AM
Biden Expects U.S. to Have Enough Vaccines for All Adults by End of May -- 6th Update Dow Jones News - 3/2/2021 10:14:00 PM
Biden Expects U.S. to Have Enough Vaccines for All Adults by End of May -- 5th Update Dow Jones News - 3/2/2021 6:56:00 PM
Merck to Help Johnson & Johnson Make Its Covid-19 Vaccine--3rd Update Dow Jones News - 3/2/2021 5:55:00 PM
Merck to Help Produce Johnson & Johnson’s COVID-19 Vaccine; BARDA to Provide Merck With Funding to Expand Merck’s Manufac... Business Wire - 3/2/2021 4:30:00 PM
Merck to Help Johnson & Johnson Make Its Covid-19 Vaccine--3rd Update Dow Jones News - 3/2/2021 2:22:00 PM
Merck to Help Johnson & Johnson Make Its Covid-19 Vaccine--2nd Update Dow Jones News - 3/2/2021 12:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:58:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:56:48 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:50:45 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:48:40 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:44:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:42:02 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:36:35 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:14:45 AM
Merck to Help J&J Make Its Covid-19 Vaccine, Biden to Announce--Update Dow Jones News - 3/2/2021 9:54:00 AM
DewDiligence Member Level  Friday, 04/24/20 12:51:00 PM
Re: None
Post # of 586 
MRK/AZN—Lynparza shows statsig-superior OS to hormonal agents (Xtandi, Zytiga) in the phase-3 PROFOUND study in second-line CRPC with certain genetic mutations:

https://www.businesswire.com/news/home/20200424005205/en

Lynparza is the only PARP inhibitor to show an OS benefit in this setting.

The PROFOUND study met its primary endpoint of radiographic PFS in Aug 2019, and the resulting NDA and MAA are currently under FDA and EMA review.

A trial of Lynparza in first-line CRPC is in progress with results expected in 2021.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences